ARTICLE | Company News
Inovio, GeneOne deal
July 20, 2015 7:00 AM UTC
The companies will co-develop Inovio’s INO-4500 vaccine against Middle East respiratory syndrome (MERS). The Phase I trial is slated to begin this year. GeneOne is responsible for running the trial a...